TP53 and familial pancreatic carcinoma: Of note, our results demonstrated glucose tolerance abnormalities in an orthotopic pancreatic cancer mouse model with TG2 and p53 combined interference, indicating a possible mechanism for hyperglycemia occurring in pancreatic cancer.